SANDOZ IBUPROFEN PLUS CODEINE film coated tablet blister pack 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

sandoz ibuprofen plus codeine film coated tablet blister pack

sandoz pty ltd - codeine phosphate hemihydrate, quantity: 12.8 mg; ibuprofen, quantity: 200 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; colloidal anhydrous silica; croscarmellose sodium; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400 - for the temporary relief of acute moderate pain and inflammation in patients over the age of 12 years (see also contraindications and paediatric use)

QUETIAPINE SANDOZ quetiapine 100 mg (as fumarate) film-coated tablet blister pack 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

quetiapine sandoz quetiapine 100 mg (as fumarate) film-coated tablet blister pack

sandoz pty ltd - quetiapine fumarate, quantity: 115.13 mg (equivalent: quetiapine, qty 100 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; calcium hydrogen phosphate dihydrate; iron oxide yellow; sodium starch glycollate type a; silicon dioxide; povidone; magnesium stearate; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 4000 - quetiapine sandoz is indicated for:,bipolar disorder adults ? maintenance treatment of bipolar i disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes ? treatment of depressive episodes associated with bipolar disorder (see dose and method of administration) ? treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate,children/adolescents aged 10 to 17 years ? monotherapy treatment of acute mania associated with bipolar i disorder,schizophrenia (adults and adolescents aged 13 to 17 years) ? treatment of schizophrenia

QUETIAPINE SANDOZ quetiapine 300 mg (as fumarate) film-coated tablet blister pack 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

quetiapine sandoz quetiapine 300 mg (as fumarate) film-coated tablet blister pack

sandoz pty ltd - quetiapine fumarate, quantity: 345.39 mg (equivalent: quetiapine, qty 300 mg) - tablet, film coated - excipient ingredients: povidone; calcium hydrogen phosphate dihydrate; silicon dioxide; lactose monohydrate; microcrystalline cellulose; magnesium stearate; sodium starch glycollate type a; titanium dioxide; hypromellose; macrogol 4000 - quetiapine sandoz is indicated for:,bipolar disorder adults ? maintenance treatment of bipolar i disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes ? treatment of depressive episodes associated with bipolar disorder (see dose and method of administration) ? treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate,children/adolescents aged 10 to 17 years ? monotherapy treatment of acute mania associated with bipolar i disorder,schizophrenia (adults and adolescents aged 13 to 17 years) ? treatment of schizophrenia

QUETIAPINE SANDOZ quetiapine 25 mg (as fumarate) film-coated tablet blister pack 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

quetiapine sandoz quetiapine 25 mg (as fumarate) film-coated tablet blister pack

sandoz pty ltd - quetiapine fumarate, quantity: 28.78 mg (equivalent: quetiapine, qty 25 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; silicon dioxide; iron oxide yellow; sodium starch glycollate type a; povidone; magnesium stearate; iron oxide red; calcium hydrogen phosphate dihydrate; titanium dioxide; hypromellose; macrogol 4000 - quetiapine sandoz is indicated for:,bipolar disorder adults ? maintenance treatment of bipolar i disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes ? treatment of depressive episodes associated with bipolar disorder (see dose and method of administration) ? treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate,children/adolescents aged 10 to 17 years ? monotherapy treatment of acute mania associated with bipolar i disorder,schizophrenia (adults and adolescents aged 13 to 17 years) ? treatment of schizophrenia

QUETIAPINE SANDOZ quetiapine  200 mg (as fumarate) film-coated tablet blister pack 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

quetiapine sandoz quetiapine 200 mg (as fumarate) film-coated tablet blister pack

sandoz pty ltd - quetiapine fumarate, quantity: 230.26 mg (equivalent: quetiapine, qty 200 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate type a; microcrystalline cellulose; lactose monohydrate; magnesium stearate; silicon dioxide; povidone; calcium hydrogen phosphate dihydrate; titanium dioxide; hypromellose; macrogol 4000 - quetiapine sandoz is indicated for:,bipolar disorder adults ? maintenance treatment of bipolar i disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes ? treatment of depressive episodes associated with bipolar disorder (see dose and method of administration) ? treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate,children/adolescents aged 10 to 17 years ? monotherapy treatment of acute mania associated with bipolar i disorder,schizophrenia (adults and adolescents aged 13 to 17 years) ? treatment of schizophrenia

BORTEZOMIB SANDOZ bortezomib 3.5 mg powder for injection vial 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

bortezomib sandoz bortezomib 3.5 mg powder for injection vial

sandoz pty ltd - bortezomib, quantity: 3.5 mg - injection, powder for - excipient ingredients: mannitol - bortezomib sandoz, in combination with melphalan and prednisone is indicated for the treatment of patients with previously untreated multiple myeloma who are not candidates for high dose chemotherapy.,bortezomib sandoz, as part of combination therapy, is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue for patients under 65 years of age with previously untreated multiple myeloma.,bortezomib sandoz is also indicated for the treatment of multiple myeloma patients who have received at least one prior therapy, and who have progressive disease.,bortezomib sandoz in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma.

Biodroxil Powder For Oral Suspension 肯尼亚 - 英文 - Pharmacy and Poisons Board

biodroxil powder for oral suspension

sandoz gmbh kundl biochemiestrasse 10a-6250 kundl / tirol austria - cefadroxil - powder for oral suspension - 125mg/5ml - beta-lactamantibacterials: first-generation

Biodroxil Powder For Oral Suspension 肯尼亚 - 英文 - Pharmacy and Poisons Board

biodroxil powder for oral suspension

sandoz gmbh kundl biochemiestrasse 10a-6250 kundl / tirol austria - cefadroxil - powder for oral suspension - 250mg/5ml - beta-lactamantibacterials: first-generation

Biodroxil 1000mg Film-Coated Tablet 肯尼亚 - 英文 - Pharmacy and Poisons Board

biodroxil 1000mg film-coated tablet

sandoz gmbh kundl biochemiestrasse 10a-6250 kundl / tirolaustria. - cefadroxil - film-coated tablet - 1000mg - beta-lactamantibacterials: first-generation